As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Podcasts|January 26, 2022
Pharmacy Focus: Student Edition - Episode 4
Even after some pharmacy school classes resumed in-person, students had myriad barriers and motivators to attending because of the COVID-19 pandemic.
Advertisement
The COVID-19 pandemic caused massive disruptions in pharmacy schools, and even once some classes resumed in-person, students had a myriad of barriers and motivators to attend. To learn more about these impacts, we spoke with Cara Rutledge, a student at the University of Texas at Austin College of Pharmacy, who researched class attendance during the pandemic.
This episode also features Carolina Mussenden, a pharmacy student at the Nova Southeastern University College of Pharmacy who is simultaneously pursuing her MBA. Mussenden discussed the importance of leadership positions as well as finding balance between academics and extracurricular activities.
Are you interested in writing for Pharmacy Times? Reach out to AAntrim@pharmacytimes.com to learn about various opportunities to get involved!
Advertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
4
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
5